Physician profile
Ayal Willner
NPI 1548334295
$12,323.91
in general payments reported to CMS, 2019-2025
30 companies · $1,094 in 2025
The $1,094 reported for 2025 was more than what 81% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,594 · 2020: $1,676 · 2021: $623 · 2022: $3,686 · 2023: $1,318 · 2024: $1,332 · 2025: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,687 · Education: $57.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,686.56 |
| Education | $57.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $2,888.38 | 2020-2022 | |
| Medtronic USA, INC. | $1,285.87 | 2019-2020 | |
| Glaxosmithkline, LLC. | $1,196.45 | 2021-2025 | Nucala |
| Checkpoint Surgical, INC | $1,191.00 | 2019 | |
| Intersect Ent, INC. | $1,024.19 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $722.89 | 2019-2025 | Dupixent |
| Genzyme Corporation | $669.26 | 2022-2025 | |
| Inspire Medical Systems, INC. | $641.91 | 2023-2025 | Inspire |
| Stryker Corporation | $600.74 | 2019-2022 | |
| Medtronic, INC. | $521.50 | 2021-2025 | Propel, Pteye Parathyroid Detection System, Nuvent |
| Acclarent, INC | $414.76 | 2019-2023 | Trudi Nav Cable, Relieva Spinplus |
| Optinose US, INC. | $204.53 | 2019-2025 | |
| Smith+Nephew, INC. | $190.83 | 2019-2025 | Tula, Halo, Rf20000 |
| Bard Access Systems, INC. | $113.47 | 2019 | |
| Phadia US INC. | $110.50 | 2020-2024 | Immunocap |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $82.40 | 2020-2023 | Ragwitek, Odactra, Grastek |
| Merck Sharp & Dohme LLC | $80.27 | 2021-2025 | Keytruda |
| Takeda Pharmaceuticals U.S.A., INC. | $74.37 | 2021 | |
| Integra Lifesciences Corporation | $59.22 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Hikma Pharmaceuticals USA | $32.88 | 2022-2025 | Ryaltris |
| Krystal Biotech INC | $28.39 | 2024 | Vyjuvek |
| Covidien LP | $24.92 | 2019 | |
| Novartis Pharmaceuticals Corporation | $24.60 | 2022 | |
| Amgen INC. | $24.49 | 2025 | Tezspire |
| Philips North America LLC | $21.59 | 2022 | |
| Baxter Healthcare | $20.33 | 2020 | |
| Olympus America INC. | $19.97 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.65 | 2025 | Tezspire |
| Lucid Diagnostics INC. | $19.55 | 2022 | |
| Glenmark Therapeutics INC. | $15.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayal Willner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.